Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists in Parkinson Disease: A Systematic Review and Meta-Analysis.

Raza H, Nizam B, Padaniya A, Farid MA, Nabi A, Hasan MQ, Salih M, Patel AH, Inam N, Rehman MEU, Khan U, Alsubari AMA

Open source

DOI
10.1002/brb3.71344
Published
2026 Apr
Container
Brain and behavior
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/brb3.71344,
  title = {Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists in Parkinson Disease: A Systematic Review and Meta-Analysis.},
  author = {Raza H and Nizam B and Padaniya A and Farid MA and Nabi A and Hasan MQ and Salih M and Patel AH and Inam N and Rehman MEU and Khan U and Alsubari AMA},
  year = {2026},
  journal = {Brain and behavior},
  doi = {10.1002/brb3.71344},
  url = {https://doi.org/10.1002/brb3.71344}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists in Parkinson Disease: A Systematic Review and Meta-Analysis.
AU  - Raza H
AU  - Nizam B
AU  - Padaniya A
AU  - Farid MA
AU  - Nabi A
AU  - Hasan MQ
AU  - Salih M
AU  - Patel AH
AU  - Inam N
AU  - Rehman MEU
AU  - Khan U
AU  - Alsubari AMA
PY  - 2026
JO  - Brain and behavior
DO  - 10.1002/brb3.71344
UR  - https://doi.org/10.1002/brb3.71344
ER  - 

APA

H, R., B, N., A, P., MA, F., A, N., MQ, H., M, S., AH, P., N, I., MEU, R., U, K., & AMA, A. (2026). Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists in Parkinson Disease: A Systematic Review and Meta-Analysis.. Brain and behavior. https://doi.org/10.1002/brb3.71344

Source records